Literature DB >> 1700600

Clinicopathologic features and long-term results of alpha-fetoprotein-producing gastric cancer.

Y C Chang1, N Nagasue, H Kohno, H Taniura, M Uchida, A Yamanoi, T Kimoto, T Nakamura.   

Abstract

During a 10-yr-period, 24 cases of alpha-fetoprotein-producing gastric cancer were experienced in our department. The mean age was 62.5 yr, and the sex ratio of males to females was 3:1. Borrmann II and III types of gastric cancer were predominant (83.3%). The prognosis was dismal. Most of the patients, including three radically operated cases of early gastric cancer, died from liver metastasis within 2 yr. The 1-, 3-, and 6-yr survival rates were 37.5%, 8.3%, and 8.3%, respectively, for all cases and 75.0%, 25.0%, and 25.0% for radically operated cases. The incidences of synchronous and metachronous liver metastasis were 31.8% and 40.9%, significantly higher than the incidences of AFP-negative gastric cancer (p less than 0.91). Despite radical gastrectomy, metachronous liver metastasis occurred in 75.0% of the cases. Two radical hepatic resections, including extended right lobectomy, were performed in one patient with early gastric cancer who had repeated metachronous liver metastasis. However, the tumor recurred immediately. Apparently, radical gastrectomy or hepatic resection alone may not suffice for this particular type of cancer. The methods of treatment and follow-up considered should be different from that for other types of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700600

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  30 in total

1.  High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer.

Authors:  A Ra Choi; Jun Chul Park; Jie-Hyun Kim; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Jae Bock Chung
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

2.  The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma.

Authors:  Yakup Bozkaya; Mutlu Doğan; Ozan Yazıcı; Gökmen Umut Erdem; Nebi Serkan Demirci; Nurullah Zengin
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

3.  Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma.

Authors:  Yakup Bozkaya; Nebi Serkan Demirci; Alican Kurtipek; Gökmen Umut Erdem; Nuriye Yildirim Ozdemir; Nurullah Zengin
Journal:  Mol Clin Oncol       Date:  2017-06-08

4.  Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.

Authors:  Takashi Murakami; Takashi Yao; Hiroyuki Mitomi; Takashi Morimoto; Hiroya Ueyama; Kenshi Matsumoto; Tsuyoshi Saito; Taro Osada; Akihito Nagahara; Sumio Watanabe
Journal:  Gastric Cancer       Date:  2015-04-18       Impact factor: 7.370

5.  Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases.

Authors:  Y U Fang; Lin Wang; Ningrong Yang; Xinlei Gong; Y U Zhang; Shukui Qin
Journal:  Oncol Lett       Date:  2015-09-21       Impact factor: 2.967

6.  Successful resection of metachronous liver metastasis from alpha-fetoprotein-producing gastric cancer: report of a case.

Authors:  Y Sato; T Nishimaki; K Date; Y Shirai; I Kurosaki; Y Saito; T Watanabe; K Hatakeyama
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Hepatoid adenocarcinoma of the stomach: A case report and literature review.

Authors:  Xiao-Mei Liu; Gui-Qiu Chen; Shun-Li Li; Tian-Shu Zai
Journal:  Exp Ther Med       Date:  2015-03-30       Impact factor: 2.447

8.  Clinical and prognostic characteristics of papillary clear carcinoma of stomach.

Authors:  K Uefuji; T Ichikura; S Tamakuma
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

9.  A giant tumor of the mesocolon found to be metastasis from an alpha-fetoprotein-producing gastric carcinoma: report of a case.

Authors:  T Kanda; J Sasaki; A Nashimoto; M Suzuki; H Tsunoda; T Muto
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

10.  Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.

Authors:  Shinji Ohashi; Shozo Okamura; Fumihiro Urano; Matsuyoshi Maeda
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.